Invesco S&P MidCap 400 Pure Growth ETF Rating $63.63 -0.02 (-0.03%) As of 08/13/2026 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Invesco S&P MidCap 400 Pure Growth ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.RFG Aggregate RatingModerate Buy 2.78Holdings in RFG have an aggregate rating of Moderate Buy based on 335 analyst ratings issued in the past year covering 25 companies (42.6% of the portfolio).RFG Aggregate Price Target$63.63High Prediction$63.63Average Prediction$63.63Low Prediction$63.63Holdings in RFG have an aggregate price target of $63.63 and a range of $63.63 to $63.63 covering 25 companies (42.6% of the portfolio).RFG Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy8 Buy rating(s)Moderate Buy14 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco S&P MidCap 400 Pure Growth ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 RFG Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.60%ARWRArrowhead Pharmaceuticals$85.59-1.9%2.051 of 5 stars2.62$97.33 13.7%132.26%STRLSterling Infrastructure$553.16+0.8%4.6232 of 5 stars2.88$657.00 18.8%8Analyst RevisionGap Up2.18%CRSCarpenter Technology$535.17+1.2%3.7409 of 5 stars3.00$577.25 7.9%10Dividend Announcement2.11%HALOHalozyme Therapeutics$100.67-1.1%3.7088 of 5 stars2.62$91.20 -9.4%13Insider Trade2.10%FTITechnipFMC$76.63+1.8%3.4213 of 5 stars2.81$69.64 -9.1%16Positive News1.95%DOCNDigitalOcean$132.40-0.7%4.2831 of 5 stars3.00$151.33 14.3%16Analyst UpgradeInsider Trade1.82%WWDWoodward$358.54-1.1%4.5152 of 5 stars2.93$406.45 13.4%141.80%MEDPMedpace$581.95-2.5%3.5391 of 5 stars2.23$584.18 0.4%13Analyst UpgradeInsider Trade1.78%MTZMasTec$285.43+1.5%4.4096 of 5 stars3.00$427.32 49.7%21Analyst Forecast1.73%IDCCInterDigital$344.07-2.1%4.4803 of 5 stars3.00$416.67 21.1%5Analyst Downgrade1.67%ATIATI$226.97-1.5%3.382 of 5 stars3.10$232.00 2.2%10Analyst Forecast1.66%FIVEFive Below$241.71+1.5%4.0956 of 5 stars2.59$262.80 8.7%32Positive NewsAnalyst Forecast1.62%VALValaris$85.27+0.1%2.3265 of 5 stars1.89$60.94 -28.5%91.58%DYDycom Industries$409.57-0.1%4.8125 of 5 stars3.00$554.92 35.5%131.53%TWLOTwilio$249.54+1.2%3.8892 of 5 stars2.96$249.68 0.1%27Analyst ForecastInsider Trade1.49%KRYSKrystal Biotech$328.34-1.4%4.0288 of 5 stars2.92$361.56 10.1%12Positive News1.48%CWCurtiss-Wright$688.49-4.9%3.9872 of 5 stars2.50$782.50 13.7%6Positive NewsAnalyst Forecast1.44%FCFSFirstCash$210.82-1.5%4.2873 of 5 stars3.00$249.00 18.1%6Positive News1.43%EXELExelixis$50.61+0.5%3.1261 of 5 stars2.32$49.79 -1.6%19Analyst UpgradeInsider Trade1.43%VICRVicor$226.64+0.2%4.5633 of 5 stars2.60$381.67 68.4%5Positive News1.42%TTMITTM Technologies$138.88+0.6%4.7672 of 5 stars3.17$214.25 54.3%6Analyst Upgrade1.40%NBIXNeurocrine Biosciences$150.82-3.6%4.9864 of 5 stars2.88$200.86 33.2%24Trending NewsAnalyst Downgrade1.38%TLNTalen Energy$358.40-1.8%4.6603 of 5 stars2.85$476.58 33.0%131.35%RMBSRambus$99.33-1.7%4.6958 of 5 stars2.73$139.78 40.7%11Positive News1.34%UTHRUnited Therapeutics$501.27-2.0%4.3665 of 5 stars2.85$646.00 28.9%13Insider Trade This page (NYSEARCA:RFG) was last updated on 8/14/2026 by MarketBeat.com Staff. From Our PartnersHow the JPMorgan $8,000 Gold Call Exposed the Biggest Mistake in Most Retirement AccountsJPMorgan has raised its 2026 gold forecast to $6,300, with a credible path to $8,000, and now calls gold a cor...Golden Crest Metals | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon advi...Paradigm Press | SponsoredTrump’s New Currency ResetTrump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...Porter & Company | SponsoredThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredAmerican retirees will miss THIS. Big Banks just moved in.Central banks spent nearly $130 billion on physical gold last year, on top of $145 billion the year before. Q1...Cedar Gold Group | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredThe Starlink of EnergyA portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...Monument Traders Alliance | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco S&P MidCap 400 Pure Growth ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco S&P MidCap 400 Pure Growth ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.